Antimicrobial Agents Practice Questions

Q: Which of the following antibiotics is used in the treatment of Clostridium difficile-associated diarrhea?

Metronidazole. **Explanation** *Clostridium difficile*-associated diarrhea (CDAD), now commonly referred to as *Clostridioides difficile* infection (CDI), occurs due to the overgrowth of toxin-producing bacteria, often following broad-spectrum antibiotic use. **Why Metronidazole is Correct:** Metronidazole is a nitroimidazole that is highly effective against anaerobic bacteria. It undergoes reductive activation within the anaerobe to form reactive intermediates that cause DNA strand breakage. Historically, oral metronidazole was the first-line agent for mild-to-moderate CDI due to its efficacy and low cost. While recent guidelines (IDSA) now favor **Fidaxomicin** or **Oral Vancomycin** as first-line for all severities, Metronidazole remains a correct and frequently tested option, especially in resource-limited settings or for initial non-severe episodes. **Why the Other Options are Incorrect:** * **Ciprofloxacin:** A fluoroquinolone that is ineffective against *C. difficile*. In fact, fluoroquinolones are common "offending agents" that predispose patients to CDI by disrupting normal gut flora. * **Piperacillin:** An antipseudomonad penicillin. Like other broad-spectrum beta-lactams, it can trigger CDI by suppressing protective intestinal microflora. * **Clindamycin:** This is the classic "culprit" antibiotic most strongly associated with causing *C. difficile* pseudomembranous colitis. It is never used for treatment. **High-Yield Clinical Pearls for NEET-PG:** * **Drug of Choice (Current):** Fidaxomicin (oral) or Vancomycin (oral). Note: Vancomycin must be given **orally** for CDI because IV vancomycin does not reach the gut lumen. * **Metronidazole:** Still used for the first episode of non-severe CDI if other options are unavailable. * **Severe/Fulminant CDI:** Treated with a combination of high-dose oral Vancomycin and IV Metronidazole. * **Mechanism of Fidaxomicin:** Inhibits RNA polymerase (sigma subunit).

Q: Amoxicillin is better than ampicillin due to which of the following reasons?

Better bioavailability when taken with food.. **Explanation:** Amoxicillin and Ampicillin are both extended-spectrum aminopenicillins, but they differ significantly in their pharmacokinetic profiles. **1. Why Option A is Correct:** The primary clinical advantage of **Amoxicillin** over Ampicillin is its superior oral absorption. Amoxicillin has a **bioavailability of approximately 90%**, and its absorption is **not affected by food**. In contrast, Ampicillin's absorption is incomplete (about 40-50%) and is further decreased when taken with food. This makes Amoxicillin more reliable for outpatient oral therapy. **2. Analysis of Incorrect Options:** * **Option B:** This is the opposite of the clinical reality. Ampicillin, not Amoxicillin, has decreased bioavailability with food. * **Option C:** While Amoxicillin is better absorbed (leaving less unabsorbed drug in the gut to cause flora disruption), the incidence of diarrhea is actually **lower** with Amoxicillin compared to Ampicillin. However, in the context of this specific question, the most definitive pharmacokinetic reason provided is the bioavailability in relation to food. * **Option D:** Both drugs have a similar antibacterial spectrum. However, **Ampicillin is actually more effective against *Shigella*** and is preferred for treating shigellosis (though resistance is common). Amoxicillin is not superior in this regard. **High-Yield NEET-PG Pearls:** * **Mnemonic:** **A**moxicillin is **A**bsorbed better. * **Drug of Choice (DOC):** Amoxicillin is the DOC for *Enterococcus* infections, *Listeria monocytogenes* (often used with Gentamicin), and prophylaxis for bacterial endocarditis. * **Side Effects:** Both can cause a non-allergic "Ampicillin rash" in patients with Infectious Mononucleosis (EBV). * **Excretion:** Both are excreted renally; dose adjustment is required in renal failure.

Q: Which of the following is a true statement about Imipenem?

It is used with cilastatin.. Explanation: 1. Why Option C is correct: Imipenem is a potent carbapenem antibiotic [2]. When administered alone, it is rapidly inactivated by the enzyme Dehydropeptidase-I (DHP-I) located in the brush border of the proximal renal tubules. This metabolism results in low urinary concentrations and the formation of potentially nephrotoxic metabolites. To prevent this, Imipenem is always co-administered with Cilastatin, a specific DHP-I inhibitor. Cilastatin ensures high therapeutic levels of the drug in the urine and protects the kidneys. 2. Why other options are incorrect: * Option A: Imipenem has an extremely broad spectrum of action, covering Gram-positive, Gram-negative, and anaerobic bacteria (including Pseudomonas and Bacteroides) [2]. * Option B: Imipenem is highly resistant to most beta-lactamases, including extended-spectrum beta-lactamases (ESBLs) [2]. This makes it a "drug of last resort" for multi-drug resistant infections. * Option D: Sulbactam is a beta-lactamase inhibitor typically paired with Ampicillin [1]. It is not used with Imipenem because Imipenem is already inherently stable against most beta-lactamases. 3. High-Yield Clinical Pearls for NEET-PG: * Seizures: Imipenem is the carbapenem most likely to cause seizures as a side effect (especially in patients with renal failure). Meropenem has a lower seizure potential. * Ertapenem: Unlike Imipenem, Ertapenem lacks activity against Pseudomonas and Acinetobacter (Mnemonic: Ertapenem is Excluded from Pseudomonas). * Carbapenemases: Resistance to Imipenem is mediated by carbapenemases (e.g., NDM-1), which are treated with newer agents like Ceftazidime-Avibactam.

Q: Which drug is used for the prophylaxis of rheumatic heart disease?

All of the above. **Explanation:**The primary goal of prophylaxis in **Rheumatic Heart Disease (RHD)** is to prevent recurrent Group A Beta-hemolytic Streptococcal (GABHS) pharyngitis, which triggers the autoimmune response leading to valvular damage. **Why "All of the above" is correct:**Prophylaxis is categorized into primary (preventing the first attack) and secondary (preventing recurrences). All three drugs listed are standard options: * **Benzathine Penicillin (Option C):** This is the **drug of choice** for secondary prophylaxis [1]. It is administered as a deep intramuscular injection every 3–4 weeks. Its long-acting nature ensures sustained plasma levels, overcoming compliance issues. * **Phenoxy-methyl Penicillin (Penicillin V) (Option B):** This is the oral alternative for patients who refuse injections [1]. However, it is less preferred due to the requirement of twice-daily dosing and poor patient compliance. * **Sulfadiazine (Option A):** This is an effective oral alternative for secondary prophylaxis in patients who are **allergic to Penicillin** [2]. It is contraindicated in pregnancy and patients with G6PD deficiency. **Clinical Pearls for NEET-PG:**1. **Drug of Choice (DOC):** Benzathine Penicillin G (1.2 million units IM).2. **Duration of Prophylaxis:** * *Rheumatic fever without carditis:* 5 years or until age 21 (whichever is longer).* *With carditis but no residual heart disease:* 10 years or until age 21.* *With residual valvular disease:* 10 years or until age 40 (sometimes lifelong).3. **Macrolides (Erythromycin/Azithromycin):** Used only if the patient is allergic to both Penicillin and Sulfonamides.4. **Infective Endocarditis (IE) Prophylaxis:** Note that RHD prophylaxis is different from IE prophylaxis (where Amoxicillin is typically used before dental procedures).

Q: What is the treatment for Respiratory Syncytial Virus (RSV)?

Ribavirin. **Explanation:** **Correct Option: B. Ribavirin** Ribavirin is a synthetic guanosine analogue that inhibits the replication of a wide range of RNA and DNA viruses. It works by interfering with the duplication of the viral genome through multiple mechanisms, including inhibition of RNA-dependent RNA polymerase and depletion of intracellular GTP pools. In clinical practice, **aerosolized Ribavirin** is specifically indicated for severe Lower Respiratory Tract Infections (LRTI) caused by **Respiratory Syncytial Virus (RSV)**, particularly in hospitalized infants and immunocompromised patients. **Analysis of Incorrect Options:** * **A. Acyclovir:** A guanosine analogue specifically used for Herpes Simplex Virus (HSV) and Varicella-Zoster Virus (VZV). It requires activation by viral thymidine kinase, which RSV lacks. * **C. Interferon:** While interferons have broad antiviral properties and are used in Hepatitis B and C, they are not the standard of care for RSV due to limited clinical efficacy and significant side effects. * **D. Abacavir:** A Nucleoside Reverse Transcriptase Inhibitor (NRTI) used exclusively in the treatment of HIV-1 infection. **High-Yield Clinical Pearls for NEET-PG:** * **Palivizumab:** A humanized monoclonal antibody directed against the **F-protein** of RSV. It is used for **prophylaxis** in high-risk infants (e.g., premature births, congenital heart disease), not for active treatment. * **Ribavirin Toxicity:** When administered systemically, it can cause **dose-dependent hemolytic anemia**. It is also highly **teratogenic** (Category X), requiring strict contraception. * **RSV Presentation:** It is the most common cause of **bronchiolitis** and pneumonia in children under 1 year of age. Look for "wheezing" and "hyperinflated lungs" in clinical vignettes.

Q: Which anti-tubercular agent is associated with side effects such as respiratory syndrome, cutaneous syndrome, flu-like syndrome, and abdominal syndrome?

Rifampicin. The correct answer is **Rifampicin**. These specific "syndromes" are characteristic adverse reactions associated with **intermittent (less than twice weekly) or high-dose** administration of Rifampicin [1]. **Why Rifampicin is correct:** Rifampicin-induced hypersensitivity reactions are thought to be mediated by the formation of antibodies against the drug. When the drug is taken irregularly, these reactions manifest as distinct clusters: * **Flu-like syndrome:** Fever, chills, and malaise (most common) [1]. * **Respiratory syndrome:** Breathlessness and wheezing. * **Abdominal syndrome:** Nausea, vomiting, and abdominal pain. * **Cutaneous syndrome:** Flushing, pruritus, and rash. * **Other severe effects:** Acute renal failure, hemolytic anemia, and thrombocytopenia [1]. **Why other options are incorrect:** * **PAS (Para-aminosalicylic acid):** Primarily causes severe GI intolerance and hypersensitivity (skin rash, fever), but not the specific systemic "syndromes" mentioned. * **Pyrazinamide:** Its hallmark side effects are **hyperuricemia** (leading to gout) and hepatotoxicity. * **Streptomycin:** An aminoglycoside known for **ototoxicity** (vestibular > cochlear) and nephrotoxicity. **NEET-PG High-Yield Pearls for Rifampicin:** 1. **Mechanism:** Inhibits DNA-dependent RNA polymerase. 2. **Secretions:** Causes harmless **orange-red discoloration** of urine, sweat, and tears (counsel the patient!). 3. **Enzyme Induction:** It is a potent **CYP450 inducer**, leading to significant drug interactions (e.g., failure of oral contraceptives or warfarin). 4. **Resistance:** Due to mutations in the *rpoB* gene.

Q: Which of the following anti-metabolites acts as an antifungal agent?

5-Flucytosine. **Explanation:** **5-Flucytosine (5-FC)** is the correct answer because it is a pyrimidine antimetabolite specifically used as an antifungal agent. **Mechanism of Action:** 5-Flucytosine is a prodrug. It is taken up by fungal cells via the enzyme **cytosine permease**. Inside the cell, it is converted by **cytosine deaminase** into **5-fluorouracil (5-FU)**. 5-FU is then metabolized into 5-fluorodeoxyuridine monophosphate (5-FdUMP), which inhibits **thymidylate synthase**, thereby halting fungal DNA synthesis. Human cells lack cytosine deaminase, which provides the drug its selective toxicity. **Analysis of Incorrect Options:** * **A. Paclitaxel:** A microtubule stabilizer (taxane) used as a cytotoxic chemotherapy agent for cancers like breast and ovarian cancer. It is not an antimetabolite. * **C. Chlorambucil:** An alkylating agent (nitrogen mustard) used primarily in the treatment of Chronic Lymphocytic Leukemia (CLL). * **D. Dacarbazine:** An alkylating agent used in the treatment of Hodgkin’s lymphoma and malignant melanoma. **High-Yield Clinical Pearls for NEET-PG:** 1. **Synergy:** 5-Flucytosine is rarely used alone due to rapid resistance development. It is most commonly combined with **Amphotericin B** for treating **Cryptococcal meningitis**. 2. **Adverse Effects:** The most significant side effect is **bone marrow suppression** (anemia, leukopenia, thrombocytopenia) and enterocolitis. 3. **Spectrum:** It is primarily active against *Cryptococcus neoformans*, *Candida* species, and some molds (Chromoblastomycosis).

Q: What is the treatment of choice for luminal infection of E. histolytica?

Paromomycin. **Explanation:** The treatment of *Entamoeba histolytica* depends on the site of infection. Amoebicides are classified into **Tissue Amoebicides** (acting in the bowel wall, liver, and other tissues) and **Luminal Amoebicides** (acting only in the intestinal lumen). **Why Paromomycin is correct:** Paromomycin is an aminoglycoside antibiotic that is not absorbed from the gastrointestinal tract. Because it remains entirely within the gut lumen, it reaches high concentrations where it directly kills trophozoites and prevents cyst formation. It is the **drug of choice for asymptomatic cyst passers** and is used to eradicate the luminal reservoir following a course of tissue amoebicides in symptomatic patients. **Analysis of Incorrect Options:** * **Metronidazole & Tinidazole:** These are Nitroimidazoles and are the drugs of choice for **invasive/tissue amoebiasis** (amoebic liver abscess or intestinal wall infection). However, they are rapidly absorbed from the small intestine and do not reach therapeutic concentrations in the colon lumen; thus, they are ineffective for eradicating luminal cysts. * **Ivermectin:** This is an antiparasitic agent used primarily for helminths (like *Strongyloides*) and ectoparasites (like Scabies). It has no activity against *E. histolytica*. **High-Yield Clinical Pearls for NEET-PG:** * **Luminal Amoebicides:** Paromomycin (preferred), Diloxanide furoate, and Iodoquinol. * **Standard Protocol:** For symptomatic amoebiasis, always follow Metronidazole (to kill tissue trophozoites) with a Luminal Amoebicide (to prevent relapse and transmission). * **Side Effect:** Paromomycin can cause GI upset and, rarely, ototoxicity if systemic absorption occurs in patients with inflammatory bowel disease.

Q: Which antimicrobial agent inhibits ergosterol biosynthesis?

Amphotericin B. The correct answer is **Amphotericin B**. This question tests your knowledge of the mechanisms of action of antifungal agents, specifically those targeting the fungal cell membrane. **1. Why Amphotericin B is Correct:** Amphotericin B is a **Polyene antibiotic** [2]. Its primary mechanism involves binding to **ergosterol**, the principal sterol in the fungal cell membrane. This binding creates transmembrane pores (channels), leading to the leakage of intracellular ions (like K+) and small molecules, ultimately causing cell death [3]. While the question asks about "inhibiting biosynthesis," in many clinical contexts and standard textbooks (like K.D. Tripathi), Polyenes are grouped under agents acting on the cell membrane by targeting ergosterol. **2. Why the Other Options are Incorrect:** * **Ciprofloxacin:** This is a Fluoroquinolone antibacterial agent. It acts by inhibiting **DNA Gyrase** (Topoisomerase II) and Topoisomerase IV, preventing bacterial DNA replication. * **5-Fluorocytosine (Flucytosine):** This is an antimetabolite. It is converted to 5-fluorouracil inside fungal cells, where it inhibits **thymidylate synthase**, thereby interfering with fungal DNA and RNA synthesis [3]. * **Griseofulvin:** This antifungal acts by binding to tubulin, which **interferes with microtubule function** and inhibits mitosis (metaphase arrest). It is used primarily for dermatophytosis. **High-Yield Clinical Pearls for NEET-PG:** * **Azoles** (e.g., Fluconazole) are the specific agents that inhibit ergosterol *biosynthesis* by inhibiting the enzyme **14-α-demethylase** [1]. * **Amphotericin B** is known for its significant toxicity, particularly **nephrotoxicity** (renal tubular acidosis and hypokalemia) [3]. * **Terbinafine** inhibits **Squalene epoxidase**, another step in ergosterol synthesis. * **Echinocandins** (e.g., Caspofungin) inhibit **β-(1,3)-D-glucan synthesis**, targeting the fungal *cell wall* rather than the membrane.

Q: Empirical use of intravenous amphotericin B is indicated in?

Non-responding febrile neutropenia. **Explanation:** The correct answer is **Non-responding febrile neutropenia**. **1. Why it is correct:** In patients with persistent fever and neutropenia (Absolute Neutrophil Count <500/mm³) who do not respond to 4–7 days of broad-spectrum antibiotics, the risk of occult invasive fungal infections (especially *Aspergillus* and *Candida*) increases significantly. Empirical antifungal therapy with **Liposomal Amphotericin B** (or Caspofungin) is the standard of care to prevent mortality before a definitive fungal diagnosis can be made. **2. Why the other options are incorrect:** * **Candida infections:** While Amphotericin B is effective, it is usually reserved for severe or systemic candidiasis. It is not used "empirically" unless the patient is hemodynamically unstable or has failed azole therapy. * **Blastomycosis:** This is a specific fungal infection where Amphotericin B is a **definitive** treatment (for severe/CNS disease), not an empirical one. It is not a common indication for empirical use in general practice. * **Larva migrans:** This is a parasitic infection (Cutaneous or Visceral). Cutaneous larva migrans is treated with **Albendazole or Ivermectin**, not antifungals. **3. High-Yield Clinical Pearls for NEET-PG:** * **Mechanism of Action:** Binds to **ergosterol** in the fungal cell membrane, creating pores that cause leakage of intracellular contents. * **Dose-limiting Toxicity:** **Nephrotoxicity** (Azotemia). Liposomal formulations are used to reduce this risk. * **Infusion-related reactions:** "Shake and bake" (fever, chills, rigors) can be premedicated with NSAIDs or hydrocortisone. * **Electrolyte disturbances:** Commonly causes **Hypokalemia** and Hypomagnesemia.

Question 1

Which of the following antibiotics is used in the treatment of Clostridium difficile-associated diarrhea?

Accepted Answer

Metronidazole

Answer

Ciprofloxacin

Answer

Piperacillin

Answer

Clindamycin

Question 2

Amoxicillin is better than ampicillin due to which of the following reasons?

Accepted Answer

Better bioavailability when taken with food.

Answer

Lesser bioavailability when taken with food.

Answer

Lower incidence of diarrhea.

Answer

More active against Shigella and H. influenza.

Question 3

Which of the following is a true statement about Imipenem?

Accepted Answer

It is used with cilastatin.

Answer

It has a narrow spectrum of action.

Answer

It is easily broken by beta-lactamase.

Answer

It is used with sulbactam.

Question 4

Which drug is used for the prophylaxis of rheumatic heart disease?

Accepted Answer

All of the above

Answer

Sulfadiazine

Answer

Phenoxy-methyl penicillin

Answer

Benzathine penicillin

Question 5

What is the treatment for Respiratory Syncytial Virus (RSV)?

Accepted Answer

Ribavirin

Answer

Acyclovir

Answer

Interferon

Answer

Abacavir

Question 6

Which anti-tubercular agent is associated with side effects such as respiratory syndrome, cutaneous syndrome, flu-like syndrome, and abdominal syndrome?

Accepted Answer

Rifampicin

Answer

PAS

Answer

Pyrazinamide

Answer

Streptomycin

Question 7

Which of the following anti-metabolites acts as an antifungal agent?

Accepted Answer

5-Flucytosine

Answer

Paclitaxel

Answer

Chlorambucil

Answer

Dacarbazine

Question 8

What is the treatment of choice for luminal infection of E. histolytica?

Accepted Answer

Paromomycin

Answer

Tinidazole

Answer

Metronidazole

Answer

Ivermectin

Question 9

Which antimicrobial agent inhibits ergosterol biosynthesis?

Accepted Answer

Amphotericin B

Answer

Ciprofloxacin

Answer

5-Fluorocytosine

Answer

Griseofulvin

Question 10

Empirical use of intravenous amphotericin B is indicated in?

Accepted Answer

Non-responding febrile neutropenia

Answer

Candida infections

Answer

Blastomycosis

Answer

Larva migrans

Antimicrobial Agents — MCQs

Antimicrobial Agents — MCQs

On this page

Practice by Chapter

Want unlimited practice?